Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Topic

Prevention interventions (remove)
- Pre-exposure prophylaxis for prevention (PrEP) (3)
- Post-exposure prophylaxis for prevention (PEP) (1)
Treatment (remove)
- HIV drugs (remove)

Filter by Infection

HIV (remove)

Filter by Resource Category

Research summary (4)

Search results

Current filters: HIV, Treatment, HIV drugs, Prevention interventions

4 search results

Truvada vs. Descovy for HIV prevention: From TreatmentUpdate 231
2019, CATIE
Research summary - Webpage
CDC recommends use of raltegravir (Isentress) for PEP: From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage
Generic tenofovir + FTC coming to Canada: 2017, CATIE
Research summary - Webpage
TAF + FTC—virus risk reduced in monkeys, but what about people?: From TreatmentUpdate 214
2016, CATIE
Research summary - Webpage

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.